Recruiting OBSERVATIONAL NCT06226987
Molecular Imaging in Fabry Disease of the Heart
Sponsor: Sanofi
Conditions
Fabry Disease, Cardiac Variant
Interventions
68Ga-DOTATATE PET/MRI
Updated 4 times since 2024 Last updated: Jul 18, 2024 Started: Jan 2, 2024 Primary completion: Jan 2, 2026 Completion: Jan 2, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Fabry Disease, Cardiac Variant, this trial is actively recruiting participants. The trial is conducted by Sanofi and has accumulated 4 data snapshots since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Jan 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Sanofi
- University of Cambridge
Data source: University of Cambridge
For direct contact, visit the study record on ClinicalTrials.gov .